Social Media Ideas for Amyloid Clearance

Clinicopathologic Study Reveals Amyloid Clearance in Alzheimer’s Disease

A recent case report published in JAMA has shed new light on the mechanisms involved in amyloid clearance following amyloid-targeting therapies for Alzheimer’s disease. This ground...

PM20D1 Creates N-oleoyl-Leucine to Improve Clearance of Amyloid-β Aggregates by Microglia

Researchers here note a mechanism that encourages the innate immune cells known as microglia to better clear amyloid-β in the aging brain. The protein PM20D1 acts in the formation...

The tough task of reversing cardiac Amyloidosis : Classification of “Anti-Amyloid”drugs

Amyloidosis is a proteostatic disease , meaning a progressive disorder of extracellular deposition of insoluble protein fibrils in tissues.It affects , brain, kidney, nerves and al...

Microglial CD31 Hinders Aβ Clearance, Worsens Alzheimer’s

In a groundbreaking study that promises to reshape our understanding of Alzheimer’s disease, researchers have unveiled a novel mechanism by which microglial cells may exacerbate di...

Amyloidosis Continues To Fight Back

Neurons’ Protein Disposal Trick Offers Alzheimer’s Insights

According to a new study, a special protein disposal system, currently found only in neurons, is linked to central hallmarks of Alzheimer’s disease [1]. The membranal proteasome Al...

A Copper-Based Drug Clears Buildup of Alzheimer's Proteins in Mice

A promising start.ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.

Copper drug clears toxic Alzheimer’s proteins and restores memory

A copper-based compound restored the brain’s ability to clear toxic Alzheimer’s proteins, dramatically reducing amyloid buildup and improving memory in laboratory experiments. The...

This Copper Drug Clears Alzheimer’s Brain Toxins and Boosts Memory

A copper-based drug helped the brain flush out Alzheimer’s toxins, cutting plaque buildup and improving memory in a promising new study. Scientists at Monash University have identi...

Using Macrophages to Clear Circulating MMP9 Improves Bone Tissue in Aging Mice

Today's open access paper combines a few interesting topics. Firstly, the researchers involved describe a way to deliver a short-lived messenger RNA gene therapy selectively to the...

Impaired Glymphatic Drainage of Cerebrospinal Fluid in Early Stages of Synucleinopathy

Age-related impairment of drainage of cerebrospinal fluid from the brain is a topic of increasing interest. This was pioneered by the work of Leucadia Therapeutics, specifically fo...

Neuronal Protein Tracing Reveals How the Brain Routes Its Waste

A new neuronal protein‑tracing method maps how waste leaves the brain through distinct, region‑specific routes. The approach shows how inflammation and Alzheimer’s derail normal cl...

Pre-Amyloidosis Red-Flag Clinical Diagnoses in Light Chain (AL) Versus Age-Related Transthyretin (ATTRwt) Amyloidosis: E...

This electronic health record–based study highlights distinct diagnostic patterns preceding a diagnosis of light chain (AL) and wild-type transthyretin (ATTRwt) amyloidosis; AL amy...

Scientists reprogram brain immune cells to fight Alzheimer’s

A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s models. The treatment reduced toxic plaque buildup and impr...

Cyclarity Therapeutics Reports Safety Data for 7-Ketocholesterol Clearance

Cyclarity Therapeutics has been processing safety data from a phase 1 safety trial of a cyclodextrin drug to bind 7-ketocholesterol, a toxic form of oxidized cholesterol that contr...

Game that reduces dementia risk may clear amyloid from men’s brains

Playing a mental speed-training game seems to help the brain clear a protein linked to Alzheimer’s disease in men, but may work in women through different mechanisms

Arc is Involved in Transmission of Tau Between Neurons in Alzheimer's Disease

The more severe later stages of Alzheimer's disease are characterized by altered forms of tau protein aggregating inside neurons to cause dysfunction, inflammation, and cell death....

TB Vaccine Flushes Alzheimer’s Amyloid

The BCG vaccine remodels the human brain’s immune environment via trained immunity. Tracking older adults over one year, researchers demonstrated that BCG enhances central nervous...

An Update on Progress at Repair Biotechnologies, Developing Means to Regress Atherosclerotic Plaque

Atherosclerosis is the development of fatty plaques that narrow blood vessels and eventually rupture to cause a stroke or heart attack, the most common cause of human mortality. At...

Scientists found a hidden Alzheimer’s trigger and shut it down

A newly identified enzyme called IDOL could become a major new target in the fight against Alzheimer’s disease. Researchers found that removing it from neurons sharply reduced amyl...

Sugar-like molecules may help immune cells clear myelin debris in MS

Novel ring-shaped sugar molecules called cyclodextrins may help promote conditions that support myelin repair in multiple sclerosis (MS) by easing harmful changes in the immune cel...

Caveolin-1 Gene Therapy Reduces TDP-43 Related Neurodegeneration in a Mouse Model

You might recall that gene therapy to overexpress caveolin-1 in the brain was recently shown to reduce pathology in a mouse model of Alzheimer's disease. In today's open access pap...

Experimental Alzheimer's drug shows promise targeting brain protein tau in study

An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers r...

New Molecule Restores the Brain’s Natural Defenses Against Alzheimer’s

Scientists have developed an experimental molecule that helps the brain’s immune cells fight Alzheimer’s again, reducing toxic plaques and improving memory in animal studies. Scien...